CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Diagnostica Stago launched its next-generation ecarin-based chromogenic assay for dabigatran, STA-ECA II. Fully automated with barcoded loading on Stago’s high throughput analyzers, STA-ECA II enables laboratories to measure dabigatran (Pradaxa) in plasma samples and is insensitive to lupus anticoagulants and heparin along with coagulation factor and fibrinogen levels. With a wide working range of 15–460 ng/mL and 28-day, 2°–8°C stability, the assay is flexible for a variety of sample testing requirements. STA-ECA II is labeled for research use only (not for use in diagnostic procedures), along with the associated dabigatran calibrators and controls.
Diagnostica Stago, 973-631-1200